{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "10200336", "DateCompleted": {"Year": "1999", "Month": "05", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1019-6439", "JournalIssue": {"Volume": "14", "Issue": "5", "PubDate": {"Year": "1999", "Month": "May"}}, "Title": "International journal of oncology", "ISOAbbreviation": "Int J Oncol"}, "ArticleTitle": "Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.", "Pagination": {"StartPage": "869", "EndPage": "875", "MedlinePgn": "869-75"}, "Abstract": {"AbstractText": ["Ginsenoside Rh2 (G-Rh2) isolated from the root of Panax ginseng has been shown to have anti-cancer proliferation, differentiation and chemopreventive effects in certain cancer cell types. We investigated the mechanism of G-Rh2-induced growth inhibition in MCF-7 human breast carcinoma cells. G-Rh2 significantly inhibited the cell growth in a concentration-dependent manner, which effect was reversible, and induced a G1 arrest in cell cycle progression. G-Rh2 treatment down-regulated the protein level of cyclin D3 but upregulated the expression of cyclin-dependent kinase (Cdk) inhibitor p21WAF1/CIP1. The increased levels of p21 were associated with increased binding of p21 and Cdk2 concomitant with marked decrease in Cdk2 and cyclin E-dependent kinase activities with no changes in Cdk2 and cyclin E expression. G-Rh2 markedly reduced the phosphorylated retinoblastoma protein (pRb) and enchanced association of unphosphorylated pRb and the transcription factor E2F-1. These data suggest that G-Rh2 inhibited the growth of MCF-7 cells, by inducing protein expression of p21 and reducing the protein levels of cyclin D which resulted in the down-regulation of cyclin/Cdk complex kinase activity, decreasing phosphorylation of pRb, and inhibiting E2F release."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Pusan National University, Pusan 609-735, Korea."}], "Identifier": [], "LastName": "Oh", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Choi", "ForeName": "Y H", "Initials": "YH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Choi", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "S I", "Initials": "SI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "N D", "Initials": "ND"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Int J Oncol", "NlmUniqueID": "9306042", "ISSNLinking": "1019-6439"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "CDKN1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Carrier Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Cell Cycle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin D"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin E"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin-Dependent Kinase Inhibitor p21"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclins"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "E2F Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "E2F1 Transcription Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "E2F1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Retinoblastoma Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Retinoblastoma-Binding Protein 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor DP1"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}, {"RegistryNumber": "78214-33-2", "NameOfSubstance": "ginsenoside Rh2"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Protein Serine-Threonine Kinases"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "CDC2-CDC28 Kinases"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "CDK2 protein, human"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinase 2"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "CDC2-CDC28 Kinases"}, {"QualifierName": [], "DescriptorName": "Carrier Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Cycle Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": [], "DescriptorName": "Cyclin D"}, {"QualifierName": [], "DescriptorName": "Cyclin E"}, {"QualifierName": [], "DescriptorName": "Cyclin-Dependent Kinase 2"}, {"QualifierName": [], "DescriptorName": "Cyclin-Dependent Kinase Inhibitor p21"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclin-Dependent Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclins"}, {"QualifierName": [], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "E2F Transcription Factors"}, {"QualifierName": [], "DescriptorName": "E2F1 Transcription Factor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G1 Phase"}, {"QualifierName": [], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Serine-Threonine Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Retinoblastoma Protein"}, {"QualifierName": [], "DescriptorName": "Retinoblastoma-Binding Protein 1"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": [], "DescriptorName": "Transcription Factor DP1"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factors"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "4", "Day": "14"}, {"Year": "1999", "Month": "4", "Day": "14", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "4", "Day": "14", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10200336", "10.3892/ijo.14.5.869"]}}], "PubmedBookArticle": []}